Clinical and economic outcomes in the treatment of lower respiratory tract infections.
Brixner
Diana I
DI
Department of Pharmacy Practice, University of Utah, Salt Lake City, USA.
D000900:Anti-Bacterial Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D029481:Bronchitis, Chronic / Q000188:drug therapy / Q000191:economics; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000191:economics*; D024881:Drug Resistance, Bacterial; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006801:Humans; D048628:Ketolides / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000191:economics; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000191:economics*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D048628:Ketolides